Phosphodiesterase inhibition by naloxone augments the inotropic actions of β-adrenergic stimulation

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 8, 2009, Pages 1043-1051

  Park, W K ^a   Chang, C H ^a   Chae, J E ^a   Kim, M H ^b   Cho, Y L ^a   Ahn, D S ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAMIDE; CYCLIC AMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; NALOXONE; PHOSPHODIESTERASE; ROLIPRAM;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART PAPILLARY MUSCLE; INOTROPISM; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL;

1-METHYL-3-ISOBUTYLXANTHINE; ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOTONIC AGENTS; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FORSKOLIN; GUINEA PIGS; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIUM; NALOXONE; NARCOTIC ANTAGONISTS; PAPILLARY MUSCLES; PHOSPHODIESTERASE INHIBITORS;

EID: 68849114300     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2009.02023.x     Document Type: Article

References (23)

1. Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. Beta-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 1977 197 : 1367 9.
2. Lechner RB, Gurll NJ, Reynolds DG. Naloxone potentiates the cardiovascular effects of catecholamines in canine hemorrhagic shock. Circ Shock 1985 16 : 347 61.
3. Lechner RB. Naloxone potentiates the inotropic effects of isoproterenol in vitro by a nonopiate receptor mechanism. Circ Shock 1992 38 : 157 64.
4. Caffrey JL, Hathorne LF, Carter GC, Sinclair RJ. Naloxone potentiates contractile responses to epinephrine in isolated canine arteries. Circ Shock 1990 31 : 317 32.
5. Gu H, Barron BA, Gaugl JF, Caffrey JL. (+)Naloxone potentiates the inotropic effect of epinephrine in the isolated dog heart. Circ Shock 1993 40 : 206 11.
6. Park WK, Kim MH, Ahn DS, Chae JE, Lee YS, Chung NS, Lynch C III. Myocardial depressant effects of desflurane. Anesthesiology 2007 106 : 956 66.
7. Schûmann HJ, Endoh M, Wagner J. Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both α- and β-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1974 284 : 133 48.
8. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951 193 : 265 75.
9. Lechner RB, Gurll NJ, Reynolds DG. Intracoronary naloxone in hemorrhagic shock: dose-dependent stereospecific effects. Am J Physiol 1985 249 : H272 7.
10. Kim KJ, Chung NS, Park WK. Direct myocardial depressant effect of naloxone: mechanical and electrophysiological actions in vitro. Acta Anaesthesiol Scand 2004 48 : 102 10.
11. Tang WJ, Hurley JH. Catalytic mechanism and regulation of mammalian adenylyl cyclase. Mol Pharmacol 1998 54 : 231 40.
12. Muller B, Lugnier C, Stoclet JC. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. J Cardiovasc Pharmacol 1990 16 : 796 803.
13. Weishaar RE, Kobylarz-Singer DC, Quade MM, Steffen RP, Kaplan HR. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility. J Cyclic Nucleotide Protein Phosphor Res 1987 11 : 513 27.
14. Gristwood RW, Sampford KA, Williams TJ. The effect of SK&F 94120, rolipram and M&B 22948 on force of contraction and cyclic nucleotide content of cat myocardium. Br J Pharmacol 1986 89 : 573P.
15. Gristwood RW, Owen DAA. Effects of rolipram on guinea-pig ventricles in vitro: evidence of an unexpected synergism with SK&F 94120. Br J Pharmacol 1986 87 : 91P.
16. Shahid M, Nicholson CD. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn Schmiedebergs Arch Pharmacol 1990 342 : 698 705.
17. Muller B, Lugnier C, Stoclet JC. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria. J Cardiovasc Pharmacol 1990 15 : 444 51.
18. Katano Y, Endoh M. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone and isobutylmethylxanthine. J Cardiovasc Pharmacol 1992 20 : 715 22.
19. Silver PJ. Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 1989 63 : 2A 8A.
20. Brunkhorst D, van der Leyen H, Meyer W, Nigbur R, Schmidt-Schumacher C, Scholz H. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart. Naunyn Schmiedebergs Arch Pharmacol 1989 339 : 575 83.
21. Ngai SH, Berkowitz BA, Yang JC, Hempstead J, Spector S. Pharmacokinetics of naloxone in rats and in man. Anesthesiology 1976 44 : 398 401.
22. Chiang CN, Hawks RL. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend 2003 70 : S39 47.
23. Groeger JS, Inturrisi CE. High-dose naloxone: pharmacokinetics in patients in septic shock. Crit Care Med 1987 15 : 751 6.